Efficacy of Mydriatic Drops in Premature Infants
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03448640|
Recruitment Status : Completed
First Posted : February 28, 2018
Last Update Posted : February 28, 2018
|Condition or disease||Intervention/treatment|
|Retinopathy of Prematurity||Drug: Drug used in the examination of premature infants.|
Purpose: To determine effect and vital change after topical application of phenylephrine 2.5% and tropicamide 0.5% three times for retinopathy of prematurity (ROP) examination in preterm infants.
Methods: Pupillary diameter, blood pressure, pulse rate, and oxygen saturation were monitored before, and after up to 24 hours 60 ROP screening examinations.
|Study Type :||Observational|
|Actual Enrollment :||60 participants|
|Official Title:||Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy|
|Actual Study Start Date :||January 15, 2016|
|Actual Primary Completion Date :||October 15, 2017|
|Actual Study Completion Date :||December 15, 2017|
- Drug: Drug used in the examination of premature infants.
to investigate side effects of eye drops usedOther Name: Tropicamide and mydfline used
- The mean pupillary diameter [ Time Frame: an average of 1 year ]will be measured with a ruler after 60 minutes instillation of mydriatic